Leading the Next Generation of Immune Defense
Monoclonal antibodies (mAbs) provide an innovative, natural pathway to fill critical gaps in current treatment and prevention strategies. As awareness and adoption of these therapies grow, mAbs can transform how we prevent and fight off infection.
Working Together to Expand Innovation
The Antibody Innovation Alliance (AIA) works to deepen awareness and accessibility of monoclonal antibodies — a safe, proven option to help prevent serious infectious diseases.
